Literature DB >> 27761744

Predominance of CRF63_02A1 and multiple patterns of unique recombinant forms of CRF63_A1 among individuals with newly diagnosed HIV-1 infection in Kemerovo Oblast, Russia.

Natalya M Gashnikova1, Darya P Zyryanova2, Ekaterina M Astakhova2, Vladimir V Ivlev2, Maria P Gashnikova2, Natalya V Moskaleva3, Sergey S Aikin3, Tatyana N Bulatova3, Sergey V Pustylnikov2,4, Evgeny F Bocharov2, Aleksey V Totmenin2.   

Abstract

Kemerovo Oblast (KO) has had the highest rate of HIV spread in Russia since 2011. The aim of this work was to study the genetic variation of HIV-1 in Kemerovo Oblast. Blood was sampled from a total of 91 HIV-positive antiretroviral-therapy-naïve individuals in 2013 (38) and 2015 (53). HIV-1 subtypes, pol gene drug resistance mutations, and viral tropism were analyzed. In 2013-2015, the prevalence of HIV-1 subtype A decreased in KO from 60.5 to 7.5 %. The samples collected in 2015 from the patients with newly diagnosed HIV demonstrate the current dominance of HIV-1 CRF63_02A1 (71.7 %) and HIV-1 URF63_A1 (20.8 %), their parental viruses being CRF63_02A1 and subtype A. The initially predominant genetic variant, HIV-1 subtype A, was replaced in KO. An unusually high incidence of HIV-1 unique recombinant forms is probably the result of HIV-1 CRF63_02A1 introduction in the group of injection drug users with the initial HIV-1 subtype A infection and the practice of risky behavior that promotes reinfection. HIV-1 CRF63_02A1, which recently emerged in Siberia, and its recombinant forms have an ever-increasing impact on the current HIV epidemic in Russia, making urgent the need for in-depth study of this HIV-1 genetic variant.

Entities:  

Mesh:

Year:  2016        PMID: 27761744     DOI: 10.1007/s00705-016-3120-4

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  6 in total

1.  Construction and Characterization of Infectious Molecular Clones of HIV-1 CRF63_02A6.

Authors:  Daria P Zyryanova; Alexei V Totmenin; Natalia V Bogacheva; Natalya M Gashnikova
Journal:  AIDS Res Hum Retroviruses       Date:  2019-10-08       Impact factor: 2.205

2.  HIV-1 Epidemiology, Genetic Diversity, and Primary Drug Resistance in the Tyumen Oblast, Russia.

Authors:  Natalya M Gashnikova; Ekaterina M Astakhova; Mariya P Gashnikova; Evgeniy F Bocharov; Svetlana V Petrova; Olga A Pun'ko; Alexander V Popkov; Aleksey V Totmenin
Journal:  Biomed Res Int       Date:  2016-11-13       Impact factor: 3.411

3.  Human Immunodeficiency Virus-1 Diversity in the Moscow Region, Russia: Phylodynamics of the Most Common Subtypes.

Authors:  Aleksey Lebedev; Natalya Lebedeva; Fedor Moskaleychik; Alexander Pronin; Elena Kazennova; Marina Bobkova
Journal:  Front Microbiol       Date:  2019-02-26       Impact factor: 5.640

4.  Molecular epidemiology of HIV-1 in Oryol Oblast, Russia.

Authors:  Ksenia R Safina; Yulia Sidorina; Natalya Efendieva; Elena Belonosova; Darya Saleeva; Alina Kirichenko; Dmitry Kireev; Vadim Pokrovsky; Georgii A Bazykin
Journal:  Virus Evol       Date:  2022-06-01

5.  Spatiotemporal dynamics of HIV-1 CRF63_02A6 sub-epidemic.

Authors:  Mariya V Sivay; Lada V Maksimenko; Irina P Osipova; Anastasiya A Nefedova; Mariya P Gashnikova; Dariya P Zyryanova; Vasiliy E Ekushov; Alexei V Totmenin; Tatyana M Nalimova; Vladimir V Ivlev; Dmitriy V Kapustin; Larisa L Pozdnyakova; Sergey E Skudarnov; Tatyana S Ostapova; Svetlana V Yaschenko; Olga I Nazarova; Aleksander S Chernov; Tatyana N Ismailova; Rinat A Maksutov; Natalya M Gashnikova
Journal:  Front Microbiol       Date:  2022-08-31       Impact factor: 6.064

6.  Genetic Diversity of HIV-1 in Krasnoyarsk Krai: Area with High Levels of HIV-1 Recombination in Russia.

Authors:  Lada V Maksimenko; Aleksey V Totmenin; Mariya P Gashnikova; Ekaterina M Astakhova; Sergey E Skudarnov; Tatyana S Ostapova; Svetlana V Yaschenko; Ivan O Meshkov; Evgeniy F Bocharov; Rinat А Maksyutov; Natalya M Gashnikova
Journal:  Biomed Res Int       Date:  2020-09-10       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.